VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Tóm tắt
Unlike during development, blood vessels in the adult are generally thought not to require VEGF for normal function. However, VEGF is a survival factor for many tumor vessels, and there are clues that some normal blood vessels may also depend on VEGF. In this study, we sought to identify which, if any, vascular beds in adult mice depend on VEGF for survival. Mice were treated with a small-molecule VEGF receptor (VEGFR) tyrosine kinase inhibitor or soluble VEGFRs for 1–3 wk. Blood vessels were assessed using immunohistochemistry or scanning or transmission electron microscopy. In a study of 17 normal organs after VEGF inhibition, we found significant capillary regression in pancreatic islets, thyroid, adrenal cortex, pituitary, choroid plexus, small-intestinal villi, and epididymal adipose tissue. The amount of regression was dose dependent and varied from organ to organ, with a maximum of 68% in thyroid, but was less in normal organs than in tumors in RIP-Tag2-transgenic mice or in Lewis lung carcinoma. VEGF-dependent capillaries were fenestrated, expressed high levels of both VEGFR-2 and VEGFR-3, and had normal pericyte coverage. Surviving capillaries in affected organs had fewer fenestrations and less VEGFR expression. All mice appeared healthy, but distinct physiological changes, including more efficient blood glucose handling, accompanied some regimens of VEGF inhibition. Strikingly, most capillaries in the thyroid grew back within 2 wk after cessation of treatment for 1 wk. Our findings of VEGF dependency of normal fenestrated capillaries and rapid regrowth after regression demonstrate the plasticity of the adult microvasculature.
Từ khóa
Tài liệu tham khảo
Benjamin LE, Hemo I, and Keshet E.A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.Development125: 1591–1598, 1998.
Bicknell Rand Harris AL.Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis.Semin Cancer Biol3: 399–407, 1992.
Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, Konerding MA, Allegrini PR, Wood J, Hennig J, Unger C, and Marmé D.PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.Cancer Res62: 4015–4022, 2002.
Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, and McMahon G.SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.Cancer Res59: 99–106, 1999.
Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, and Ferrara N.VEGF is required for growth and survival in neonatal mice.Development126: 1149–1159, 1999.
Hu-Lowe D, Heller D, Brekken J, Feely R, Amundson K, Haines M, Troche G, Kim Y, Gonzalez D, Herrman M, Batago M, Vekich S, Kania R, McTigue M, Gregory S, Bender S, and Shalinsky D.Pharmacological activities of AG-013736, a small molecule inhibitor of VEGF/PDGF receptor tyrosine kinases.Proc Am Assoc Cancer Res43: A5357, 2002.
Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TAT, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, and Cherrington JM.SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.Cancer Res60: 4152–4160, 2000.
Palade GE, Simionescu M, and Simionescu N.Structural aspects of the permeability of the microvascular endothelium.Acta Physiol Scand Suppl463: 11–32, 1979.
Renkin EM.Relation of capillary morphology to transport of fluid and large molecules: a review.Acta Physiol Scand Suppl463: 81–91, 1979.
Roberts WGand Palade GE.Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.J Cell Sci108: 2369–2379, 1995.
Simionescu Mand Simionescu N.Ultrastructure of the microvascular wall: functional correlations. In:Microcirculation: Part 1, edited by Renkin EM and Michel CC. Bethesda, MD: Am. Physiol. Soc. 1984, p. 41–101.
Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, and Halmesmaki E.Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia.Obstet Gynecol95: 353–357, 2000.